Cargando…
Sildenafil citrate and uteroplacental perfusion in fetal growth restriction
BACKGROUND: To determine whether the phosphodiesterase type 5 inhibitor, Sildenafil citrate, affects uteroplacental perfusion. MATERIALS AND METHODS: Based on a randomized double-blinded and placebo-controlled trial, forty one pregnant women with documented intrauterine growth retardation at 24-37 w...
Autores principales: | Dastjerdi, Marzieh Vahid, Hosseini, Sayedehafagh, Bayani, Leila |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685778/ https://www.ncbi.nlm.nih.gov/pubmed/23798922 |
Ejemplares similares
-
Sildenafil Citrate in Fetal Growth Restriction
por: Panda, Subrat, et al.
Publicado: (2014) -
Sildenafil citrate for the management of fetal growth restriction and oligohydramnios
por: Choudhary, Rana, et al.
Publicado: (2016) -
Sildenafil Citrate Increases Fetal Weight in a Mouse Model of Fetal Growth Restriction with a Normal Vascular Phenotype
por: Dilworth, Mark Robert, et al.
Publicado: (2013) -
Premature ovarian failure in a woman with a balanced 15;21 translocation: a case report
por: Hosseini, Sayedehafagh, et al.
Publicado: (2011) -
Why sildenafil and sildenafil citrate monohydrate crystals are not stable?
por: Sawatdee, Somchai, et al.
Publicado: (2015)